The viral tropism of two distinct oncolytic viruses, reovirus and myxoma virus, is modulated by cellular tumor suppressor gene status von Kim, M, Williamson, C T, Prudhomme, J, Bebb, D G, Riabowol, K, Lee, P W K, Lees-Miller, S P, Mori, Y, Rahman, M M, McFadden, G, Johnston, R N

Volltext

Exercise preferences, levels and quality of life in lung cancer survivors von Leach, H. J., Devonish, J. A., Bebb, D. G., Krenz, K. A., Culos-Reed, S. N.

Volltext

A catalyst for transforming health systems and person-centred care: Canadian national position statement on patient-reported outcomes von Ahmed, S., Barbera, L., Bartlett, S. J., Bebb, G. D., Brundage, M., Bryan, S., Cheung, W. Y., Coburn, N., Crump, T., Cuthbertson, L., Howell, D., Klassen, A. F., Leduc, S., Li, M., Mayo, N. E., McKinnon, G., Olsen, R., Pink, J., Robinson, J. W., Santana, M. J., Sawatzky, R., Moxam, R. S., Sinclair, S., Servidio-Italiano, F., Temple, W.

Volltext

ATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition von Bebb, D G, Petersen, L F, Moore, J, Elegbede, A, Lees-Miller, S

Volltext

Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy von Ho, C.K, Kornaga, E.N, Klimowicz, A.C, Enwere, E.K, Dean, M, Bebb, G.D, Phan, T, Ghatage, P, Magliocco, A.M, Lees-Miller, S.P, Doll, C.M

Volltext

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective von Bebb, D G, Agulnik, J, Albadine, R, Banerji, S, Bigras, G, Butts, C, Couture, C, Cutz, J C, Desmeules, P, Ionescu, D N, Leighl, N B, Melosky, B, Morzycki, W, Rashid-Kolvear, F, Lab, Clin, Sekhon, H S, Smith, A C, Stockley, T L, Torlakovic, E, Xu, Z, Tsao, M S

Volltext

Reasons for lack of referral to medical oncology for systemic therapy in stage IV non-small-cell lung cancer: comparison of 2003-2006 with 2010-2011 von Ko, J J, Tudor, R, Li, H, Liu, M, Skolnik, K, Boland, W Kells, Macklow, J, Morris, D, Bebb, D G

Volltext

Canadian perspectives: update on inhibition of ALK -positive tumours in advanced non-small-cell lung cancer von Melosky, B, Cheema, P, Agulnik, J, Albadine, R, Bebb, D G, Blais, N, Burkes, R, Butts, C, Card, P B, Chan, A M Y, Hirsh, V, Ionescu, D N, Juergens, R, Morzycki, W, Poonja, Z, Sangha, R, Tehfe, M, Tsao, M S, Vincent, M, Xu, Z, Liu, G

Volltext

Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer von BEBB, D. G, YU, Z, CHEN, J, TELATAR, M, GELMON, K, PHILLIPS, N, GATTI, R. A, GLICKMAN, B. W

Volltext

Canadian consensus: inhibition of ALK-positive tumours in advanced non-small-cell lung cancer von Melosky, B, Agulnik, J, Albadine, R, Banerji, S, Bebb, D G, Bethune, D, Blais, N, Butts, C, Cheema, P, Cheung, P, Cohen, V, Deschenes, J, Ionescu, D N, Juergens, R, Kamel-Reid, S, Laurie, S A, Liu, G, Morzycki, W, Tsao, M S, Xu, Z, Hirsh, V

Volltext

15PATM loss in NSCLC increases sensitivity to cisplatin and PARP inhibition von Bebb, D G, Petersen, L F, Moore, J, Elegbede, A, Lees-Miller, S

Volltext

Addressing disease progression in EGFRmut+ NSCLC patients von Tudor, R., Kopciuk, K., D'Silva, A., Brenner, D., Morris, D., Bebb, D.G.

Volltext

Reaching the pinnacle of stage III NSCLC treatment von D'Silva, A., Lau, H., Otsuka, S., Tudor, R., Bebb, D.G.

Volltext

Potential Therapeutic Implications of Altered Atm and P53 Status in Solid Tumours von Bebb, D.G., Elegbede, A.A., Kubota, E., Petersen, L.F., Otsuka, S.M., Lees-Miller, S.P.

Volltext

Poster session 4. Molecular diagnosis & biomarkers von Lynch, J. A., Choi, C. M., Park, Y. S., Lee, J. C., Park, M. J., Kim, H. R., Shih, N. Y., Chang, G. C., Tseng, S. W., Liu, K. J., Hsiao, K. C., Lin, H. C., Wang, J. Y., Tsai, H. L., Barak, V., Chen, Y. J., Hsieh, Y. L., Chien, P. H., Chien, Y. F., Huang, W. C., Lin, S. R., Chung, F. Y., Yen, L. C., Rixe, O., Salkeni, A. M., Furgason, J. M., McPherson, C., Warnick, R., Bahassi, M., Hembrough, T. A., Catenacci, D. V. T., Liao, W. L., Thyparambil, S., Xu, P., Henderson, L., Burrows, J., Bebb, D. G., Elegbede, A. A., Kubota, E., Petersen, L. F., Otsuka, S. M., Lees-Miller, S. P.

Volltext

Effect of inhibition of PARP-1 on mantle cell lymphoma cells with dysfunctional ATM von Williamson, C., Bebb, D. G., Muzik, H., Lees-Miller, S. P.

Volltext

Preliminary results of an escalating dose phase I clinical trial of the anti-EGFR monoclonal antibody nimotuzumab in combination with external radiotherapy in patients diagnosed wi... von Bebb, D. G., Brade, A. M., Smith, C., Rorke, S., Sherman, I.

Volltext

Consequences of modifying an adjuvant treatment protocol for resected gastric carcinoma: A retrospective study at a single institution in western Canada von Bebb, D. G., Ziouzina, O., Lupichuk, S., Stefaniuk, M., Dowden, S., Chan, A., Walley, B., Chan, S., Wong, A., Doll, C.

Volltext

Previously documented mutations in the epidermal growth factor receptor (EGFR) gene in a non-small cell lung cancer (NSCLC) population treated with gefitinib are not associated wit... von Bebb, D. G., Pugh, T., Sutcliffe, M., Barclay, L., Fee, J., O’Connor, R., Vielkind, J., Murray, N., Laskin, J. J., Marra, M.

Volltext

Guideline-indicated treatments and diagnostics, GRACE risk score, and survival for non-ST elevation myocardial infarction von Hall, Marlous, Bebb, Owen J, Dondo, Tatandashe B, Yan, Andrew T, Goodman, Shaun G, Bueno, Hector, Chew, Derek P, Brieger, David, Batin, Philip D, Farkouh, Michel E, Hemingway, Harry, Timmis, Adam, Fox, Keith A A, Gale, Chris P

Volltext